Third time lucky? Getting a grip on matrix metalloproteinases

The Journal of Biological Chemistry
F Xavier Gomis-Rüth

Abstract

Drug candidates against matrix metalloproteinases (MMPs) failed in the clinic in the past because their strong zinc-targeting warheads led to a lack of specificity. More recently, significant selectivity among MMPs was achieved by blocking the enzymes' specificity pockets, nearby exosites, and downstream domains. Scannevin and colleagues now elegantly twist the plot and achieve ultimate selectivity: They target MMP-9 by allosterically preventing activation of its zymogen.

References

Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H E Van Wart, H Birkedal-Hansen
Sep 5, 2002·Nature Reviews. Cancer·Christopher Mark Overall, Carlos López-Otín
Jun 15, 1962·Proceedings of the National Academy of Sciences of the United States of America·J GROSS, C M LAPIERE
Apr 21, 2009·Biochimica Et Biophysica Acta·Cynthia TallantF Xavier Gomis-Rüth
Dec 25, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jack Caton, Maria Emanuel Ryan
Apr 2, 2013·Trends in Pharmacological Sciences·Antoine Dufour, Christopher M Overall
Jan 18, 2015·Matrix Biology : Journal of the International Society for Matrix Biology·Gregg B Fields

❮ Previous
Next ❯

Citations

Dec 19, 2019·Periodontology 2000·Lorne M Golub, Hsi-Ming Lee
May 19, 2018·Chemical Reviews·Joan L ArolasF Xavier Gomis-Rüth

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.